Save the date: CVU Thursday 29 October 2026

MVEC’s Clinical Vaccinology Update (CVU) returns in 2026! The CVU offers healthcare professionals the opportunity to hear from leading experts on the latest developments and trends in immunisation.

日期: Thursday 29 October 2026
地点: The University of Melbourne

Stay tuned for more details.

In the meantime, we would like to gauge interest in an accredited, bespoke, immunisation-centred CPR refresher (HLTAID009) and anaphylaxis training session as an optional add-on to the CVU, delivered in collaboration with PAEDS Education.

MVEC has previously offered this training as part of an Immunisation Skills Workshop. Participants have described the training as:

  • "Relevant and supportive"
  • "Great education and hands on experience"
  • "Very informative and friendly staff"

Please submit your expression of interest via this form.


Pharmacy Daily: Pharmacists are ready for flu season

As influenza vaccinations start to roll out nationwide and the Australian community is being urged to get their shots, pharmacists are being reminded of the critical role they play. 

Read the full article at Pharmacy Daily: Pharmacists are ready for flu season. 

Learn more about influenza prevention in 2026 at MVEC:流感.


Victorian Department of Health: Expanded access to the Japanese encephalitis vaccine for people visiting high-risk areas

Eligibility to receive a free Japanese encephalitis (JE) vaccine has been temporarily expanded until 30 June 2026 to include people who plan to visit high-risk local government areas in Victoria for outdoor recreation.

Spread to humans through mosquito bites, JE is a leading cause of vaccine-preventable encephalitis (brain inflammation) in Asia and the Western Pacific.

Read the Department’s full health advisory on expanded access at Expanded access to the Japanese encephalitis vaccine for people visiting high-risk areas.

To learn more about JE disease and prevention, visit MVEC:日本脑炎.


New PDF resources available

MVEC has recently added a digital version of our ‘Vaccine guide for older adults’ booklet to our website. Designed for consumers, this booklet provides an outline of vaccines recommended for older adults, as well as helpful advice such as how to prepare for a vaccine, where to access vaccines and answers to common questions.

Visit our media library to access this resource and more.


ABC: How boosting vaccinations could prevent meningitis outbreak in Australia

As the UK responds to a growing meningococcal B outbreak which has caused 2 deaths, ABC explores prevention and treatment in Australia.

Meningococcal disease can be caused by infection with any subtypes of the bacteria Neisseria meningitidis. Of the 13 known subtypes, 5 are vaccine-preventable: A, C, W, Y and B. MVEC strongly recommends everyone wishing to be protected against ACWY and B strains of meningococcal disease be immunised.

For more information on meningococcal, visit MVEC:脑膜炎球菌.

Read the full ABC article at ABC: How boosting vaccinations could prevent meningitis outbreak in Australia.


NCIRS: RSV vaccines and prevention programs: evidence, safety and impact (webinar)

这 国家免疫研究和监测中心 (NCIRS) will host a webinar providing an overview of the evolving RSV immunisation landscape. 

日期: 23 April 2026
时间: 12:00–1:30 pm (AEST) 

Learn more and register now on the NCIRS event page. 

To learn more about RSV disease and prevention, visit MVEC: RSV. 


Immunisation Coalition: Free Influenza Vaccination Days 2026

This April this Immunisation Coalition is holding free flu vaccination clinics in Melbourne, Sydney and Canberra.

Learn more on the Immunisation Coalition event page.

To learn more about influenza disease and prevention in 2026, visit MVEC:流感. 


Immunisation Coalition: 2026 Influenza webinar

Next month, the Immunisation Coalition will host a webinar providing an update on influenza vaccination. Moderated by Dr Andrew Minton, the webinar will feature Angela Newbound.  

日期: 8 April 2026
时间: 6:00–7:00 pm (AEST)  

Learn more and register on the Immunisation Coalition’s event page 

MVEC:流感


New immunisation reference page: Dengue

Dengue, or dengue fever, is a viral illness caused by infection with the dengue virus (DENV). Primarily transmitted via mosquitos, dengue is endemic in more than 100 countries across tropical and sub-tropical areas in the Pacific, Asia, Africa and the America.

MVEC has recently published a new immunisation reference page on dengue, which includes information on symptoms and transmission, epidemiology, and prevention.

MVEC: Dengue


更新免疫参考页:流感

MVEC’s influenza reference page has been updated to include the latest recommendations and advice for the 2026 season. This includes a summary of vaccine brand for use in each age group as well as commonly asked questions.

Annual influenza vaccination is recommended for everyone aged 6 months and older. Influenza infection can cause a spectrum of symptoms, from mild cough and cold features to systemic illnesses with multiple complications. Pregnant women, children under 5 years, those aged over 65 years, people with underlying medical conditions, and Aboriginal and Torres Strait Islander peoples carry the highest rates of morbidity and mortality within Australia.

MVEC:流感

(NB: translated versions of the updated influenza reference page will be available soon)


关于 MVEC

墨尔本疫苗教育中心 (MVEC) 是一个教育网站,旨在为医疗保健专业人员和公众提供最新的免疫接种信息。我们位于研究机构默多克儿童研究所 (MCRI),隶属于维多利亚疫苗安全服务机构 SAEFVIC(社区接种疫苗后的不良事件监测)。